Cargando…
Hydroxychloroquine lung pharmacokinetics in critically ill patients with COVID-19
Different dosage regimens of hydroxychloroquine (HCQ) have been used to manage COVID-19 (coronavirus disease 2019) patients, with no information on lung exposure in this population. The aim of our study was to evaluate HCQ concentrations in the lung epithelial lining fluid (ELF) in patients infected...
Autores principales: | Ruiz, S., Concordet, D., Lanot, T., Georges, B., Goudy, P., Baklouti, S., Mané, C., Losha, E., Vinour, H., Rousset, D., Lavit, M., Minville, V., Conil, J-M, Gandia, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd and International Society of Antimicrobial Chemotherapy.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698654/ https://www.ncbi.nlm.nih.gov/pubmed/33259916 http://dx.doi.org/10.1016/j.ijantimicag.2020.106247 |
Ejemplares similares
-
Hypoalbuminemia and Pharmacokinetics: When the Misunderstanding of a Fundamental Concept Leads to Repeated Errors over Decades
por: Gandia, Peggy, et al.
Publicado: (2023) -
“De-Shrinking” EBEs: The Solution for Bayesian Therapeutic Drug Monitoring
por: Baklouti, Sarah, et al.
Publicado: (2022) -
Influence of extracorporeal membrane oxygenation on the pharmacokinetics of ceftolozane/tazobactam: an ex vivo and in vivo study
por: Mané, Camille, et al.
Publicado: (2020) -
Risk factors and the resistance mechanisms involved in Pseudomonas aeruginosa mutation in critically ill patients
por: Druge, Stéphanie, et al.
Publicado: (2019) -
Multivariate Exact Discrepancy: A New Tool for PK/PD Model Evaluation
por: Baklouti, Sarah, et al.
Publicado: (2023)